AntriaBio

About AntriaBio

AntriaBio is a biopharmaceutical company developing novel therapeutics to treat metabolic diseases.

Learn more about us ›
Compound Program Pre-Clinical Phase 1 Phase 2

AB101

Once-a-week injectible basal insulin for Diabetes

Pre-Clinical Phase in progress

Drug Pipeline

In addition to AB101, AntriaBio may use its formulation capabilities for a variety of opportunities across multiple indications.

Learn more ›